114 related articles for article (PubMed ID: 21735691)
1. [Hereditary ovarian cancer. The role of BRCA1 gene dysfunction in response to chemotherapy].
Blecharz P; Karolewski K; Urbański K
Ginekol Pol; 2011 Mar; 82(3):214-20. PubMed ID: 21735691
[TBL] [Abstract][Full Text] [Related]
2. Hereditary ovarian cancer.
Prat J; Ribé A; Gallardo A
Hum Pathol; 2005 Aug; 36(8):861-70. PubMed ID: 16112002
[TBL] [Abstract][Full Text] [Related]
3. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
4. Pattern and chemosensitivity of ovarian cancer in patients with BRCA1/2 mutations.
Ragupathy K; Ferguson M
J Obstet Gynaecol; 2011; 31(2):178-9. PubMed ID: 21281038
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer associated with inherited mutations in BRCA1 or BRCA2.
Swisher E
Curr Womens Health Rep; 2003 Feb; 3(1):27-32. PubMed ID: 12521547
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Pal T; Permuth-Wey J; Betts JA; Krischer JP; Fiorica J; Arango H; LaPolla J; Hoffman M; Martino MA; Wakeley K; Wilbanks G; Nicosia S; Cantor A; Sutphen R
Cancer; 2005 Dec; 104(12):2807-16. PubMed ID: 16284991
[TBL] [Abstract][Full Text] [Related]
7. [Management of hereditary ovarian cancer].
Joó JG; Ládi S; Nagy BZ; Langmár Z
Orv Hetil; 2011 Oct; 152(40):1596-608. PubMed ID: 21945869
[TBL] [Abstract][Full Text] [Related]
8. "BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations.
Tan DS; Rothermundt C; Thomas K; Bancroft E; Eeles R; Shanley S; Ardern-Jones A; Norman A; Kaye SB; Gore ME
J Clin Oncol; 2008 Dec; 26(34):5530-6. PubMed ID: 18955455
[TBL] [Abstract][Full Text] [Related]
9. [Hereditary forms of ovarian cancer].
de Pauw A; Jolissaint L; Fréneaux P; Rouleau E; Stoppa-Lyonnet D; Buecher B
Bull Cancer; 2012 Apr; 99(4):453-62. PubMed ID: 22361722
[TBL] [Abstract][Full Text] [Related]
10. The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.
Malander S; Rambech E; Kristoffersson U; Halvarsson B; Ridderheim M; Borg A; Nilbert M
Gynecol Oncol; 2006 May; 101(2):238-43. PubMed ID: 16360201
[TBL] [Abstract][Full Text] [Related]
11. Nonequivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutations.
George J; Alsop K; Etemadmoghadam D; Hondow H; Mikeska T; Dobrovic A; deFazio A; ; Smyth GK; Levine DA; Mitchell G; Bowtell DD
Clin Cancer Res; 2013 Jul; 19(13):3474-84. PubMed ID: 23633455
[TBL] [Abstract][Full Text] [Related]
12. Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas.
Swisher EM; Gonzalez RM; Taniguchi T; Garcia RL; Walsh T; Goff BA; Welcsh P
Mol Cancer; 2009 Jul; 8():48. PubMed ID: 19602291
[TBL] [Abstract][Full Text] [Related]
13. [Effectiveness of platinum-based chemotherapy in ovarian cancer patients with BRCA1/2 mutations].
Gorodnova TV; Maksimov SIa; Guseĭnov KD; Imianitov EN
Vopr Onkol; 2014; 60(3):339-42. PubMed ID: 25033687
[TBL] [Abstract][Full Text] [Related]
14. Hereditary breast and ovarian cancer susceptibility genes (review).
Kobayashi H; Ohno S; Sasaki Y; Matsuura M
Oncol Rep; 2013 Sep; 30(3):1019-29. PubMed ID: 23779253
[TBL] [Abstract][Full Text] [Related]
15. Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy.
Schrader KA; Hurlburt J; Kalloger SE; Hansford S; Young S; Huntsman DG; Gilks CB; McAlpine JN
Obstet Gynecol; 2012 Aug; 120(2 Pt 1):235-40. PubMed ID: 22776961
[TBL] [Abstract][Full Text] [Related]
16. Hereditary ovarian cancer: biology, response to chemotherapy and prognosis.
Safra T
Womens Health (Lond); 2009 Sep; 5(5):543-53. PubMed ID: 19702453
[TBL] [Abstract][Full Text] [Related]
17. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
[TBL] [Abstract][Full Text] [Related]
18. Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations.
Golmard L; Delnatte C; Laugé A; Moncoutier V; Lefol C; Abidallah K; Tenreiro H; Copigny F; Giraudeau M; Guy C; Barbaroux C; Amorim G; Briaux A; Guibert V; Tarabeux J; Caputo S; Collet A; Gesta P; Ingster O; Stern MH; Rouleau E; de Pauw A; Gauthier-Villars M; Buecher B; Bézieau S; Stoppa-Lyonnet D; Houdayer C
Oncogene; 2016 Mar; 35(10):1324-7. PubMed ID: 26028024
[TBL] [Abstract][Full Text] [Related]
19. [Hereditary ovarian carcinomas: clinico-biological features and treatment].
Floquet A; Stoeckle E; Croce S; Longy M; Mc Grogan G; Barouk E; Bubien V; Garbay D; Joly E; Guyon F
Bull Cancer; 2014 Feb; 101(2):167-74. PubMed ID: 24555961
[TBL] [Abstract][Full Text] [Related]
20. Identification of germline genetic mutations in patients with pancreatic cancer.
Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]